Zacks Investment Research upgraded shares of Harte-Hanks Inc. (NYSE:HHS) from a hold rating to a buy rating in a research note released on Tuesday. They currently have $2.00 price target on the stock.
According to Zacks, “Harte-Hanks is a worldwide direct and targeted marketing company that provides marketing services and shopper advertising opportunities to local, regional, national and international consumer and business-to-business marketers. Harte-Hanks Direct Marketing improves return on its clients’ marketing investment by increasing their prospect and customer value a process of customer optimization organized around five strategic considerations: Information data collection/management — Opportunity data access/utilization — Insight data analysis/interpretation — Engagement knowledge application — Interaction program execution. Expert in integrating this process, Harte-Hanks Direct Marketing is highly skilled at tailoring solutions for each of the vertical markets it serves. “
Other research analysts have also issued reports about the company. Singular Research cut their target price on Harte-Hanks from $4.50 to $3.80 and set a buy rating on the stock in a research report on Tuesday, June 21st. BMO Capital Markets reaffirmed a hold rating on shares of Harte-Hanks in a research report on Monday, July 18th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of $3.45.
Shares of Harte-Hanks (NYSE:HHS) opened at 1.53 on Tuesday. The firm’s 50-day moving average price is $1.61 and its 200-day moving average price is $1.72. Harte-Hanks has a one year low of $0.85 and a one year high of $4.35. The stock’s market capitalization is $94.11 million.
Harte-Hanks (NYSE:HHS) last issued its quarterly earnings results on Tuesday, August 9th. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by $0.04. Harte-Hanks had a positive return on equity of 1.11% and a negative net margin of 38.76%. The business had revenue of $97.30 million for the quarter, compared to analysts’ expectations of $116.25 million. During the same period in the prior year, the company earned $0.04 EPS. The company’s revenue for the quarter was down 10.9% compared to the same quarter last year. Equities research analysts anticipate that Harte-Hanks will post ($0.02) EPS for the current fiscal year.
Hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its stake in shares of Harte-Hanks by 98,406.7% in the first quarter. JPMorgan Chase & Co. now owns 470,862 shares of the company’s stock valued at $1,192,000 after buying an additional 470,384 shares in the last quarter. Foundry Partners LLC bought a new stake in shares of Harte-Hanks during the third quarter valued at about $655,000. Renaissance Technologies LLC increased its stake in shares of Harte-Hanks by 41.1% in the first quarter. Renaissance Technologies LLC now owns 643,200 shares of the company’s stock valued at $1,627,000 after buying an additional 187,500 shares in the last quarter. Royce & Associates LP increased its stake in shares of Harte-Hanks by 28.2% in the second quarter. Royce & Associates LP now owns 803,400 shares of the company’s stock valued at $1,277,000 after buying an additional 176,830 shares in the last quarter. Finally, Paloma Partners Management Co bought a new stake in shares of Harte-Hanks during the second quarter valued at about $277,000. Hedge funds and other institutional investors own 44.58% of the company’s stock.
Harte Hanks, Inc is a multi-channel marketing company. The Company operates through two segments, which include Customer Interaction and Trillium Software. The Customer Interaction segment provides a range of integrated, multi-channel, data-driven solutions for a range of brands around the globe. The Trillium Software segment is engaged in providing enterprise data quality solutions.